MED MATTERS LTD

Company Registration Number:
07773448 (England and Wales)

Unaudited abridged accounts for the year ended 29 September 2023

Period of accounts

Start date: 01 October 2022

End date: 29 September 2023

MED MATTERS LTD

Contents of the Financial Statements

for the Period Ended 29 September 2023

Balance sheet
Notes

MED MATTERS LTD

Balance sheet

As at 29 September 2023


Notes

2023

2022


£

£
Fixed assets
Tangible assets: 3 79,370 2,211
Total fixed assets: 79,370 2,211
Current assets
Debtors:   908,532 824,805
Cash at bank and in hand: 442 2,659
Total current assets: 908,974 827,464
Creditors: amounts falling due within one year:   (455,067) (409,704)
Net current assets (liabilities): 453,907 417,760
Total assets less current liabilities: 533,277 419,971
Creditors: amounts falling due after more than one year:   (146,736) (114,195)
Provision for liabilities:   (553)
Total net assets (liabilities): 386,541 305,223
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 386,441 305,123
Shareholders funds: 386,541 305,223

The notes form part of these financial statements

MED MATTERS LTD

Balance sheet statements

For the year ending 29 September 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 15 October 2024
and signed on behalf of the board by:

Name: Ross Tyler Burgess
Status: Director

The notes form part of these financial statements

MED MATTERS LTD

Notes to the Financial Statements

for the Period Ended 29 September 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MED MATTERS LTD

Notes to the Financial Statements

for the Period Ended 29 September 2023

2. Employees

2023 2022
Average number of employees during the period 0 0

MED MATTERS LTD

Notes to the Financial Statements

for the Period Ended 29 September 2023

3. Tangible Assets

Total
Cost £
At 01 October 2022 5,409
Additions 84,224
At 29 September 2023 89,633
Depreciation
At 01 October 2022 3,198
Charge for year 7,065
At 29 September 2023 10,263
Net book value
At 29 September 2023 79,370
At 30 September 2022 2,211

MED MATTERS LTD

Notes to the Financial Statements

for the Period Ended 29 September 2023

4. Loans to directors

Name of director receiving advance or credit: Ross Tyler Burgess
Description of the loan: Med Matters have receivable of £477,188 from Mr. Ross Tyler Burgess for the year ended 29 Sep 2023
£
Balance at 01 October 2022 430,430
Advances or credits made: 46,758
Balance at 29 September 2023 477,188